title: Attention-Deficit/Hyperactivity Disorder.
authors.affiliation: Department of Paediatrics, Alberta Children's Hospital, University of Calgary, #200, 233-16th Avenue North West, Calgary, Alberta T2M 0H5, Canada. Electronic address: aleung@ucalgary.ca.
authors.forename: Alexander K C
authors.initials: AK
authors.lastname: Leung
authors.affiliation: Department of Paediatrics, Chinese University of Hong Kong, 6/F, Clinical Sciences Building, Prince of Wales Hospital, Shatin, Hong Kong, China.
authors.forename: Kam Lun
authors.initials: KL
authors.lastname: Hon
mesh_terms: D018759:Adrenergic Uptake Inhibitors / Q000627:therapeutic use; D058647:Adrenergic alpha-2 Receptor Agonists / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use; D001289:Attention Deficit Disorder with Hyperactivity / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy*; D000697:Central Nervous System Stimulants / Q000627:therapeutic use; D002648:Child; D015897:Comorbidity; D003937:Diagnosis, Differential; D006801:Humans; D008487:Medical History Taking; D009483:Neuropsychological Tests; D010290:Parents / Q000193:education; D010808:Physical Examination; D011379:Prognosis; D011613:Psychotherapy
chemical_list: D018759:Adrenergic Uptake Inhibitors; D058647:Adrenergic alpha-2 Receptor Agonists; D000928:Antidepressive Agents; D000697:Central Nervous System Stimulants
keywords: Atomoxetine; Attention-deficit; Behavioral intervention; Educational intervention; Hyperactivity; Stimulants; α(2)-Adrenergic agonists